期刊文献+

血清PON1联合AGR检测对膀胱癌根治术后尿道复发的预测价值 被引量:2

Predictive value of serum PON1 combined with AGR detection for bladder carcinoma urethral recurrence after radical cystectomy
下载PDF
导出
摘要 目的探讨血清对氧磷酶1(PON1)联合白蛋白/球蛋白比值(AGR)对膀胱癌根治术后尿道复发的预测价值。方法选取接受膀胱癌根治术的183例患者为研究对象,根据随访期间的尿道复发情况将患者分为复发组和未复发组,比较两组术前血清PON1、AGR水平及临床病理特征,采用多因素logistic回归分析膀胱癌根治术后尿道复发的危险因素;通过绘制受试者工作特征(ROC)曲线,分析术前血清PON1、AGR水平对膀胱癌根治术后尿道复发的预测价值。结果随访期间3例失访,180例患者纳入研究,膀胱癌根治术后患者共有23例尿道复发,复发率12.78%。复发组术前血清PON1水平低于未复发组(P<0.05),复发组年龄、术前血清AGR水平高于未复发组(P<0.05),复发组肿瘤直径>3 cm、多发、临床分期T_(3a)~T_(4a)期、病理分级为高级别、侵犯前列腺、接受非原位可控尿道改道术患者占比均高于未复发组(P<0.05)。多因素logistic回归分析显示:年龄、肿瘤直径>3 cm、临床分期T_(3a)~T_(4a)期、病理分级为高级别、侵犯前列腺、接受非原位可控尿道改道术及术前血清低PON1水平、术前血清高AGR水平均是膀胱癌根治术后尿道复发的危险因素(P<0.05)。术前血清PON1、AGR单独及二者联合预测膀胱癌根治术后尿道复发的曲线下面积(AUC)分别为0.803、0.881、0.897。结论术前血清PON1水平降低和AGR水平升高均是膀胱癌根治术后尿道复发的危险因素,术前血清PON1和AGR可作为预测此类患者术后尿道复发的辅助指标。 Objective To evaluate the predictive value of serum serum paraoxonase 1(PON1)and albumin/globulin ratio(AGR)in bladder carcinoma urethral recurrence after radical cystectomy.Methods 183 patients who underwent radical bladder cancer surgery in our hospital were selected.According to the urethral recurrence during the follow-up period,the patients were divided into recurrence group and non-recurrence group.The preoperative serum PON1,AGR levels and clinicopathological features were compared between the two groups.Multivariate logistic regression analysis was used to analyze the risk factors of urethral recurrence after radical bladder cancer surgery.The predictive value of preoperative serum PON1 and AGR levels for urethral recurrence after radical bladder cancer surgery were analyzed by drawing receiver operating characteristic(ROC)curve.Results During the follow-up period,3 cases were lost to follow-up,and 180 patients were included in the study.A total of 23 patients had urethral recurrence after radical bladder cancer surgery,with a recurrence rate of 12.78%.The preoperative serum PON1 level in the recurrence group was significantly lower than that in the non-recurrence group(P<0.05).The age and preoperative serum AGR level in the recurrence group were significantly higher than those in non-recurrence group(P<0.05).The proportion of patients in the recurrence group with tumor diameter>3 cm,multiple occurrence,clinical stage T_(3a)-T_(4a),high-grade pathological grade,invasion of prostate and non-in situ controlled urethral diversion surgery were higher than those in the non-recurrence group(P<0.05).Multivariate Logistic regression analysis showed that age,tumor diameter>3 cm,clinical stage T_(3a)-T_(4a),high-grade pathological grade,invasion of prostate,non-in situ controlled urethral diversion surgery,preoperative serum low PON1 level and preoperative serum high AGR level were all risk factors for urethral recurrence after radical bladder cancer(P<0.05).The area under the ROC curve(AUC)of preoperative PON1 and
作者 盛永亮 吕双武 张扬 刘春辉 李志军 SHENG Yong-liang;LYU Shuang-wu;ZHANG Yang;LIU Chun-hui;LI Zhi-jun(Department of Urology Surgery,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,Henan,China)
出处 《广东医学》 CAS 2022年第9期1150-1154,共5页 Guangdong Medical Journal
基金 河南省医学科技攻关计划项目(201601637)。
关键词 膀胱癌根治术 尿道复发 血清对氧磷酶1 白蛋白/球蛋白比值 radical bladder cancer surgery urethral recurrence serum paraoxonase 1 albumin/globulin ratio
  • 相关文献

参考文献6

二级参考文献44

  • 1曲华伟,赵勇,张太健,尉春晓,宋伟,金讯波.根治性经尿道绿激光汽化治疗浸润性膀胱癌(附10例报道)[J].泌尿外科杂志(电子版),2013,5(2):21-23. 被引量:3
  • 2张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon: IARC, 1991:101- 107. 被引量:1
  • 5Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon: IARC, 1994: 35-49. 被引量:1
  • 6Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38. 被引量:1
  • 7Felay J. The IARCcrgTools program, http://www, iacr. com. fr/ iarccrgtools, htm. IACR. Lyon. 2006. 被引量:1
  • 8李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡:第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289. 被引量:1
  • 9李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡:第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295. 被引量:1
  • 10李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡:第3卷(1999-2002).北京:人民卫生出版社,2007:314-316. 被引量:1

共引文献78

同被引文献20

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部